LRI Investments’s Idexx Laboratories IDXX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$76.9K Buy
146
+6
+4% +$3.37K 0.01% 489
2026
Q1
$78.7K Buy
140
+9
+7% +$5.77K 0.01% 453
2025
Q4
$88.6K Buy
131
+2
+2% +$1.36K 0.01% 441
2025
Q3
$82.4K Hold
129
0.01% 458
2025
Q2
$69.2K Hold
129
0.01% 496
2025
Q1
$54.2K Hold
129
0.01% 528
2024
Q4
$53.3K Hold
129
0.01% 519
2024
Q3
$54.7K Hold
129
0.01% 499
2024
Q2
$62.8K Buy
129
+23
+22% +$11.5K 0.01% 456
2024
Q1
$57.2K Buy
+106
New +$57.9K 0.01% 258

Other funds holding IDXX

LRI Investments's IDXX Position: Q2 2026 in Review

LRI Investments increased its Idexx Laboratories (IDXX) stake by 4.3% in Q2 2026, buying an estimated $3.37K and bringing the position to 146 shares worth $76.9K. The position accounts for 0.01% of the portfolio, ranked #489.

LRI Investments first reported a position in IDXX in Q1 2024 and has held it in 10 quarters since. The position peaked at $88.6K in Q4 2025. 509 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.

  • LRI Investments held 146 shares of Idexx Laboratories worth $76.9K as of Q2 2026.
  • LRI Investments bought 6 Idexx Laboratories shares in Q2 2026, an estimated $3.37K.
  • Idexx Laboratories made up 0.01% of LRI Investments's portfolio in Q2 2026, its #489 holding.
  • LRI Investments first reported a position in Idexx Laboratories in Q1 2024 and has held it in 10 quarters since.
  • LRI Investments's Idexx Laboratories position peaked at $88.6K in Q4 2025.
  • 509 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.

Based on LRI Investments's 13F filing for Q2 2026, filed 14 Jul 2026.